TY - JOUR JO - Reumatologia/Rheumatology SN - 0034-6233 VL - 55 IS - 6 PY - 2017 ID - Filipowicz-Sosnowska2017 TI - Drug-free remission: the goal of the future in management of patients with rheumatoid arthritis AB - Management of patients with rheumatoid arthritis according to the “treat-to-target” strategy requires achievement of remission or low disease activity when remission cannot be achieved (mostly in patients with advanced disease). The assessment of remission and low disease activity is based on a number of definitions depending on the applied instruments which do not always correspond to one another. The role of biomarkers and imaging techniques (ultrasound and magnetic resonance imaging) in predicting the risk for disease relapse after achieving remission and tapering disease-modifying antirheumatic drugs treatment are presented. The concept of achieving the full control of inflammation including residua synovial inflammation and drug free-remission is discussed. AU - Filipowicz-Sosnowska, Anna SP - 284 EP - 289 DA - 2017 DO - 10.5114/reum.2017.72625 UR - http://dx.doi.org/10.5114/reum.2017.72625 ER -